NCT06279260 National Robotics-Assisted Radical Prostatectomy Database
| NCT ID | NCT06279260 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Melbourne Health |
| Condition | Database |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2050-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2024-07-01 with a primary completion date of 2050-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients. Studies conducted so far are small scale studies and the results from these studies cannot be generalized to the population at large in Australia. So, there is need for a largescale study that will look at the long-term outcomes and the factors that impact robotic surgeries across the metropolitan and rural hospital sectors. Hence, this comprehensive database has been setup to collaborate with major hospitals, across metropolitan and rural areas in Australia. Through this database, researchers will be able to explore the diagnostic pathway for Prostate cancer and understand the long-term benefits of robotic surgery through patient reported questionnaires. Outcomes from this database will also help compare the quality of care against other powerhouses of robotic surgery. Eventually, the database aims to standardize diagnostic pathways and clinical notes that are the same across different hospitals conducting robotic-assisted surgeries for Prostatectomy and improve care for prostate cancer patients across the country.
Eligibility Criteria
Inclusion Criteria: To be eligible to participate in this database, an individual must meet all of the following criteria: 1. Individuals who consent to participate, 2. within the age range of 18 to 90 years, 3. confirmed diagnosis of localized prostate cancer (PCa) 4. patients receiving medical attention at hospitals engaged in collaborative efforts with the designated database. Exclusion Criteria: 1. Participants are not eligible to take part in the database: 2. Individuals who have not undergone robotic surgery for prostatectomy or TP biopsy. , 3. without a diagnosis of prostate cancer or 4. who decline to provide consent for the collection of their health information 5. Under the age of 18 years.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06279260 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 90 Years, studying Database. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06279260 currently recruiting?
Yes, NCT06279260 is actively recruiting participants. Contact the research team at lawrentschuk@gmail.com for enrollment information.
Where is the NCT06279260 trial being conducted?
This trial is being conducted at Ballarat, Australia, Geelong, Australia, Melbourne, Australia, Melbourne, Australia and 4 additional locations.
Who is sponsoring the NCT06279260 clinical trial?
NCT06279260 is sponsored by Melbourne Health. The trial plans to enroll 10,000 participants.